A Lysosome-Targetable Fluorescence Probe Based on L-Cysteine-Polyamine-Morpholine-Modified Quantum Dots for Imaging in Living Cells
Received 16 October 2019
Accepted for publication 24 February 2020
Published 9 March 2020 Volume 2020:15 Pages 1611—1622
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 4
Editor who approved publication: Dr Mian Wang
Zhi-Qiang Zhang, Wen-Jing Yao, Lu-Lu Qiao, Xiaojing Yang, Jiahua Shi, Mei-Xia Zhao
Key Laboratory of Natural Medicine and Immune Engineering, Henan University, Kaifeng 475004, People’s Republic of China
Correspondence: Mei-Xia Zhao
Key Laboratory of Natural Medicine and Immune Engineering, Henan University, Jinming Road, Kaifeng 475004, People’s Republic of China
Email [email protected]
Purpose: Quantum dots (QDs) are used as fluorescent probes due to their high fluorescence intensity, longevity of fluorescence, strong light-resistant bleaching ability and high light stability. Therefore, we explore a more precise probe that can target an organelle.
Methods: In the current study, a new class of fluorescence probes were developed using QDs capped with 4 different L-cysteine-polyamine-morpholine linked by mercapto groups. Ligands were characterised by Electrospray ionization mass spectrometry (ESI-MS), H-Nuclear Magnetic Resonance (1H NMR) spectroscopy, and 13C NMR spectroscopy. Modified QDs were characterized by Transmission Electron Microscope (TEM), Ultraviolet and visible spectrophotometry (UV–Vis), and fluorescence microscopy. And the biological activity of modified QDs was explored by using MTT assay with HeLa, SMMC-7721 and HepG2 cells. The fluorescence imaging of modified QDs was obtained by confocal laser scanning fluorescence microscopy (CLSM).
Results: Synthesized QDs ranged between 4 to 5 nm and had strong optical emission properties. UV–Vis and fluorescence spectra demonstrated that the cysteine-polyamine-morpholine were successfully incorporated into QD nanoparticles. The MTT results demonstrated that modified QDs had lesser cytotoxicity when compared to unmodified QDs. In addition, modified QDs had strong fluorescence intensity in HeLa cells and targeted lysosomes of HeLa cells.
Conclusion: This study demonstrates the modified QDs efficiently entered cells and could be used as a potential lysosome-targeting fluorescent probe.
Keywords: quantum dots, fluorescence probe, lysosome-targetable, cells imaging
Quantum dots (QDs) have range of applications as nano-fluorescent probes and antitumor drug carriers, due to their unique optical properties and electronic structure.1–6 Although QDs have strong fluorescence intensity, long fluorescence lifetime and high light stability, QDs generally have poor water solubility, high toxicity and poor cell targeting ability.7–13 It is well known that hydrophobic QDs can be engineered to have great water solubility through surface-exchange of hydrophobic surfactant molecules for hydrophilic ligands.14–18 In addition, the cytotoxicity of QDs can be reduced and targeting of tumor cells can be enhanced through modification of QD surfaces using biomolecules.19–23 Therefore, when interfaced with biological molecules including proteins, peptides, carbohydrates or DNA, the resulting QD-biocomposites have widespread applicability in areas ranging from cellular fluorescence imaging to in vivo fluorescence imaging.24–30 However, following surface modification of QDs, it is important to retain its fundamental properties, such as uniform dispersion and to ensure that functional groups remain available for biological applications.31–35 As a result, development of targetable fluorescent probe QDs with fundamental properties of bio-molecules.
Polyamines are widely distributed in the body, and are associated with cell proliferation and differentiation process.36–40 In recent years, polyamine derivatives have attracted increasing attention due to their ability to enhance the selectivity and bioactivity of compounds.41–46 Protein primary structure consists of amino acids linked by peptide bonds. Because amino acids are generally water-soluble and inexpensive, they have been used as capping agents for QDs.47–51 Amino acid contain an amino and carboxyl group, therefore they can be directly linked to the surface of QDs and other drugs with the antitumor activity or targetable groups.52–57
In this paper, we synthesized a new class of modified QDs with small size, good water solubility, disperse uniformly and strong optical emission properties. In such models, four types of amino acid-polyamine-morpholine derivatives were used and the bio-activities of modified QDs were greatly improved. Since the polyamine or its derivatives are able to mimic the environment of the second coordination sphere in the active site of the corresponding enzyme. The modified QDs were characterized by transmission electron micrographs (TEM), UV–Visible Spectrophotometer (UV–Vis), and fluorescence spectrophotometer. Biological activity of modified QDs was explored using the MTT assay with HeLa, SMMC-7721 and HepG2 cells. Results demonstrated that modified QDs were less toxic to these cells. Fluorescence imaging of modified QDs with confocal laser scanning fluorescence microscopy (CLSM) demonstrated strong fluorescence intensity in targeted lysosomes of HeLa cells.
Materials and Methods
All reagents were purchased from commercial suppliers and used without further purification. Solvents were purified by standard methods prior to use. Cervical cancer cells (HeLa), human hepatoma cells (SMMC-7721) and human hepatoma cells (HepG2) were obtained from the Shanghai Cell Bank of the Chinese Academy of Sciences.
1H NMR spectra were recorded on a Bruker AV-400 spectrometers. ESI-MS spectra were performed on a Thermo LCQ-DECA-XP spectrometer. UV–Vis spectra were monitored using a Varian Cary 300 UV–Vis spectrophotometer. Fluorescence spectra were measured using a Varian Cary Eclipse fluorescence spectrophotometer (American, Agilent, Co.). Confocal microscopy images were obtained using a confocal laser scanning fluorescence microscope (Leica SP8, Germany). The cell fluorescence intensity was measured using a FACSCalibur flow cytometer (Becton Dickinson & Co., Franklin Lakes, NJ).
Synthesis of L-Cysteine-2-Amino-3-Mercapto-N-(3- Morpholinopropyl) propanamide (L-Cys-MPA) (Scheme 1)
A 250 mL round bottomed flask equipped with a magnetic stirring bar was charged with Boc-Cys(trt)-OH (2.0 g, 3.5 mmol) (1) dissolved in 100 mL acetonitrile and 0.59 g (3.5 mmol) NHS. Next, EDC (0.89 g, 3.5 mmol) was added dropwise and stirred at 0°C for 2 hrs. Then the reaction mixture was stirred at room temperature overnight. After completion, the precipitate was filtered, extracted with chloroform and vacuum dried to produce a slightly yellow solid.
N-aminopropylmorpholine (0.5 g, 3.5 mmol), compound 2, and NaHCO3 (0.35 g, 4.2 mmol) were placed in a 100 mL round-bottomed flask with a magnetic stirrer, and stirred at 60°C for 12 hrs. Next, the reaction mixture was evaporated to dryness under reduced pressure and extracted with chloroform. After vacuum drying, the solid was purified by silica gel column chromatography using a CH2Cl2-CH3OH (v:v = 20:1) mixture as the eluent to obtain the yellow grease compound 3.
Compound 3 was dissolved in 10 mL CH2Cl2 in a 50 mL three-necked flask, and then trifluoroacetic acid (TFA) (9.5 mL) and triethyl silicane 0.5 mL were injected sequentially under nitrogen protection. The resulting solution was stirred at 25°C for 6 hrs. After completion, the reaction mixture was evaporated to dryness under reduced pressure, and the residues were extracted with dichloromethane and distilled water. Removal of the solvent from the aqueous phase resulted in a solid compound 2-amino-3-mercapto-N-(3-morpholinopropyl) propanamide (L-Cys-MPA).
L-Cys-MPA, yield: 75%; 1H NMR (300 MHz, D2O) δ 3.98 (dd, J=7.4, 4.5 Hz, 2H), 3.92 (d, J=1.5 Hz, 1H), 3.71–3.55 (m, 2H), 3.41–3.30 (m, 2H), 3.20 (q, J=7.2 Hz, 2H), 3.04 (dt, J=12.3, 4.5 Hz, 4H), 2.88 (dd, J=5.9, 2.1 Hz, 2H), 1.90–1.76 (m, 2H); 13C NMR (75 MHz, D2O) δ 168.03, 163.35, 162.87, 162.40, 161.93, 121.97, 118.11, 114.25, 110.39, 63.66, 54.67, 54.42, 51.67, 51.65, 36.38, 24.62, 22.98; ESI-MS, m/z: 248.09 [M+H]+.
Synthesis of L-Cysteine-N1-(3-Morpholinopropyl) Propane-1,3-Diamine (L-Cys-MPPDA), L-Cysteine-N1-(4-Morpholinobutyl) Butane-1,4-Diamine (L-Cys-MBBDA) (Scheme 2)
A 100 mL round-bottom flask equipped with a magnetic stirring bar was charged with N-aminopropylmorpholine (1.4 g, 10 mmol) dissolved in 50 mL acetonitrile and K2CO3 (2.1 g, 15 mmol). Then N-(3-Bromopropyl) phthalimide (2.7 g, 10 mmol) or N-(4-Bromobutyl) phthalimide (2.8 g, 10 mmol) was added and stirred at 25°C for 12 hrs. After completion, the reaction mixture was evaporated to dryness under reduced pressure, and the residues were extracted with dichloromethane and 10% Na2CO3. Removal of the solvent in the organic phase resulted in a yellow compound 4a or 4b. Then compound 4a or 4b was dissolved in 50 mL methyl alcohol and (Boc)2O (3.3 g, 15 mmol) was added and the solution was stirred at 25°C for 12 hrs. After completion, the reaction mixture was evaporated to dryness under reduced pressure. After vacuum drying, the resulting solid was purified on a silica gel column using a CH2Cl2-CH3OH (v:v = 20:1) mixture as the eluent to obtain the grease compound 5a or 5b. Compound 5a or 5b was then dissolved in 50 mL absolute ethyl alcohol, and hydrazine hydrate (NH2NH2) (5 mL) was added and stirred for at 25°C for 12 hrs. The resulting mixture was evaporated to dryness under reduced pressure, and the residues extracted with CH2Cl2 and 10% Na2CO3. Following removal of the solvent, the solid compound 6a or 6b was produced. Synthesis of 7a or 7b, L-Cys-MPPDA and L-Cys-MBBDA was completed using a similar method but with compound 3 and L-Cys-MPA.
L-Cys-MPPDA, yield: 76%; 1H NMR (300 MHz, D2O) δ 4.10 (d, J=3.0 Hz, 2H), 4.05 (d, J=3.0 Hz, 1H), 3.78 (t, J=13.5Hz, 2H), 3.50 (d, J=12.0 Hz, 2H), 3.32 (dd, J=12.1, 5.2 Hz, 1H), 3.27–3.18 (m, 3H), 3.18–3.00 (m, 6H), 2.20–2.05 (m, 2H), 1.89 (p, J=7.0 Hz, 2H). 13C NMR (75 MHz, D2O) δ 168.12, 63.64, 54.41, 53.60, 51.73, 45.31, 44.26, 36.41, 25.33, 24.64, 20.32. ESI-MS, m/z: 305.20 [M+H]+.
L-Cys-MBBDA, yield: 79%; 1H NMR (300 MHz, D2O) δ 4.08 (d, J=6.0 Hz, 2H), 4.04 (t, J=4.5 Hz, 1H), 3.74 (t, J=12 Hz, 2H), 3.45 (d, J=6.0Hz, 2H), 3.33–3.09 (m, 4H), 3.09–2.94 (m, 6H), 1.83–1.47 (m, 8H). 13C NMR (75 MHz, D2O) δ 167.73, 163.49, 163.02, 162.55, 162.08, 122.07, 118.21, 114.35, 110.49, 63.70, 56.22, 54.48, 51.61, 47.09, 46.61, 38.84, 25.37, 24.76, 22.97, 22.59, 20.32. ESI-MS, m/z: 333.29 [M+H]+.
Synthesis of L-Cysteine-N1-(3-Aminopropyl)-N3-(3- Morpholinopropyl) propane-1,3-Diamine (L-Cys-AMPDA) (Scheme 3)
A 100 mL round-bottomed flask equipped with a magnetic stirring bar was charged with 6a (3.0 g, 10 mmol) dissolved in 50 mL acetonitrile solution and K2CO3 (2.1 g, 15 mmol). Then, N-(3-Bromopropyl) phthalimide (2.7 g, 10 mmol) was added and stirred at 25°C for 12 hrs. After completion, the reaction mixture was evaporated to dryness under reduced pressure, and the residues extracted with CH2Cl2 and 10% Na2CO3. Removal of the solvent in the organic phase resulted in a yellow greasy compound, termed compound 8. Then the compound 8 was dissolved in 50 mL methyl alcohol solution. (Boc)2O (3.3 g, 15 mmol) was added and the mixture was stirred at 25°C for 12 hrs. The resulting reaction mixture was concentrated under vacuum and further purified by silica gel column chromatography to obtain a greasy compound, termed compound 9. Next, the compound 9 was dissolved in 50 mL ethyl alcohol and the hydrazine hydrate (NH2NH2) (5 mL) was added. The solution stirred at 25°C for 12 hrs. After completion, the reaction mixture was evaporated to dryness under reduced pressure, and the residues were extracted with CH2Cl2 and 10% Na2CO3. The organic phases were then dried with Na2SO4 under vacuum to yield compound 10. Synthesis of compound 11 and L-Cys-AMPDA can refer to the synthetic method of compound 3 and L-Cys-MPA.
L-Cys-AMPDA, yield: 70%; 1H NMR (300 MHz, Deuterium Oxide) δ 4.18 (d, J=6.0 Hz, 2H), 4.12 (s, 1H), 3.83 (t, J=12.0 Hz, 2H), 3.56 (d, J=12.0 Hz, 2H), 3.45–3.22 (m, 6H), 3.22–3.04 (m, 10H), 2.25–2.04 (m, 4H), 1.96 (q, J=7.3 Hz, 2H). 13C NMR (75 MHz, D2O) δ 163.10, 162.63, 118.18, 114.32, 63.68, 54.45, 53.60, 51.77, 45.32, 44.57, 44.39, 36.46, 29.74, 25.36, 24.67, 22.60, 20.32. ESI-MS, m/z: 364.32 [M+H]+.
Synthesis of Water-Soluble Amino Acid-Polyamine-Morpholine-Modified QDs
QDs (1 mL) (CdSe or CdSe/ZnS or CdSe/CdS) in 1 mL of chloroform, amino acid-polyamine-morpholine (300 mg) in 3 mL triple distilled and water and 10 drops triethanolamine were placed in a bottle, and sonicated for 4 hrs. After completion, ethyl acetate was added to precipitate nanocrystal complexes to purify nanocrystals. The solid was filtered and dried under vacuum to obtain the water-soluble amino acid-polyamine-morpholine derivatives modified QDs.
Three types of cells (HeLa, SMMC-7721, HepG2) were cultured in RMPI-1640 medium at 37°C under 5% CO2. These cells were allowed to grow in a monolayer in a tissue culture flask.
Cell Cytotoxicity Test
Antitumor activity of modified QDs was monitored using a modified MTT method. Briefly, cells were seeded into 96-well plates at 5×104 cells per well. After 12 hrs, the modified QDs (50, 100, 200, 500 and 1000 μg/mL) were subsequently added and incubated for 48 hrs. Next, 20 μL MTT (2.5 mg/mL) was added to each well and after 4 hrs, supernatant was removed and 100 μL DMSO was added to each well for 10–15 mins. The absorbance was measured at a wavelength of 570 nm and the inhibition of cell growth was calculated for each concentration of the samples.
Cellular Uptake of Modified QDs
HeLa cells were seeded in a 35 mm diameter utensil containing 15 mm diameter glass cover-slips, in culture medium containing 10% FBS incubated for 24 hrs at 37°C and 5% CO2. The modified QDs were then added at the indicated time points (1, 2, 6, 12, and 24 hrs). Then, cells were washed twice with PBS buffer, and incubated with Hoechst 33342 (10 μg/mL) for 30 mins at 37°C. The cells were washed with PBS, and viewed using a confocal microscope (Leica-SP8) at an excitation wavelength of 488 nm and emission wavelength between 580 and 650 nm. Cell nuclei stained with Hoechst 33342 were observed at a wavelength of 405 nm, and emission wavelength between 430 and 480 nm.
Targeted Localization of Modified QDs in Cells
HeLa cells were seeded in a 35 mm diameter utensil containing 15 mm diameter glass cover-slips, in culture medium containing 10% FBS and incubated for 24 hrs at 37°C and 5% CO2. Then the modified QDs (200 μg/mL) were added to the utensil and incubated for 6 hrs. The cells were thoroughly washed with PBS buffer to remove QDs which were not absorbed. Then the cells were incubated for 30 mins at 37°C with the green fluorescent probe LysoTracker Green DND-26 (1 μM), and then rinsed twice with PBS. The images of the cells were obtained using a fluorescence microscope. The excitation wavelength of the QDs was 488 nm, and the emission wavelength was 580–650 nm. The excitation wavelength of LysoTracker green DND-26 was 488 nm. The band path for the marker imaging was between 500 and 560 nm.
Results and Discussion
Synthesis and Characterization
In this work, three kinds of QDs (CdSe, CdSe/ZnS, and CdSe/CdS) were prepared using an organic phase synthesis method. And four kinds of amino acid-polyamine-morpholine derivatives, L-Cysteine-2-amino-3-mercapto-N-(3-morpholinopropyl) propanamide (L-Cys-MPA), L-Cysteine-N1-(3-morpholinopropyl) propane-1,3-diamine (L-Cys-MPPDA), L-Cysteine-N1-(4-morpholinobutyl) butane-1,4-diamine (L-Cys-MBBDA), and L-Cysteine-N1-(3-aminopropyl)-N3-(3-morpholinopropyl) propane-1,3-diamine (L-Cys-AMPDA), were connected to the surface of QDs. Synthesized ligands were characterised by ESI-MS, 1H NMR spectroscopy, and 13C NMR spectroscopy. In addition, we characterized the size and dispersion of original QDs and cysteine-polyamine-morpholine-modified QDs using TEM. As shown in Figure 1, the cysteine-polyamine-morpholine-modified QDs maintained uniform dispersion and a spherical shape when suspended in PBS. Namely, the modified QDs had good water solubility and dispersed evenly.
Figure 1 TEM images and size distribution of CdSe/ZnS QDs (A, C) and CdSe/ZnS@L-Cys-MPPDA QDs (B, D) (scale bars = 50 nm).
QDs had improved better optical properties when measured using UV/Vis spectra and fluorescence spectroscopy. Figure 2 presents absorption spectra of original QDs and the cysteine-polyamine-morpholine modified QDs, where it is clear the UV–Vis absorption spectra of QDs had absorption properties typical of CdSe, CdSe/CdS, and CdSe/ZnS QDs. The shell would not affect peak position of the absorption spectra of QDs due to the high energy band gap of ZnS in comparison to that of either CdS or CdSe.58 Absorbance peak of modified QDs has a slight red-shift relative to that of the original QD nanoparticles. Therefore, it is likely that the cysteine-polyamine-morpholine has been successfully incorporated into QD nanoparticles.
Figure 2 UV–Vis spectra of original QDs and cysteine-polyamine-morpholine-modified QDs.
The original QDs and cysteine-polyamine-morpholine-modified QDs were further characterized by fluorescence spectroscopy. As shown in Figure 3, the fluorescence peak of cysteine-polyamine-morpholine modified QDs exhibited a slight red-shifted emission spectra when compared with that of corresponding QDs, suggesting that the elicited wavelengths arose due to recombination of cysteine-polyamine-morpholine derivatives on the surface of QDs. Bands of fluorescence of modified QDs were broad and significantly more intense when compared to that of original QDs. Differences in bands of fluorescence among QDs were likely due to recombination of cysteine-polyamine-morpholine derivatives on their surface.
Figure 3 Fluorescence spectra of original QDs and cysteine-polyamine-morpholine-modified QDs.
Cell Cytotoxicity Assay
In order to explore the cell toxicity of original QDs, amino acid-polyamine-morpholine-modified QDs, HeLa, SMMC-7721 and HepG2 cells were treated with different concentrations of samples for 48 hrs. Cytotoxicity was measured using the MTT assay. The IC50 values of original QDs and cysteine-polyamine-morpholine-modified QDs in HeLa, SMMC-7721 and HepG2 cells are presented in Table 1. Calculated IC50 values demonstrate that original QDs have greater cytotoxicity when compared with cysteine-polyamine-morpholine-modified QDs. Because CdSe QDs may slowly release the toxic CdII ions into solution, it is expected that particles would be inert for a short period of time during in vitro application. The release of CdII from the particle surface can be reduced using core/shell particles or coating of the particles with biomolecules or a polymer. Results of this study indicate that the developed cysteine-polyamine-morpholine-modified QDs reduce release of toxic CdII ions from QDs.
Table 1 IC50 Values of Modified and Unmodified QDs to HeLa, SMMC-7721 and HepG2 Cells
Fluorescent Labeling of Cells
The unique optical properties of QDs make them useful as biological fluorescent probes.59,60 Laser scanning confocal microscopy was used to study fluorescence intensity of cysteine-polyamine-morpholine-modified QDs at different concentrations across time. Since CdSe/ZnS@L-Cys-MPPDA QDs showed good optical properties and minimal toxicity in this work, they were used as a representative QDs in subsequent experiments. Figure 4 presents changes in fluorescence intensity of CdSe/ZnS@L-Cys-MPPDA QDs at different concentrations in cells. As concentration increased, more CdSe/ZnS@L-Cys-MPPDA QDs entered the cell and a concomitant increase in fluorescence intensity was observed. Furthermore, it was observed that QDs selectively accumulated in the cytoplasm of cells. Accumulation of CdSe/ZnS@L-Cys-MPPDA QDs (200 μg/mL) in HeLa cells over differing incubation periods was monitored (Figure 5). As presented in Figure 5, fluorescence intensity of QDs in cells gradually increased with incubation time and reached a plateau in the cytoplasm after 6 hrs. Remarkably, the fluorescence intensity of QDs in cells did not decrease following 24 hrs incubation. Thus, the fluorescence intensity of CdSe/ZnS@L-Cys-MPPDA QDs treated cells increased with increasing concentrations and incubation times. So the cysteine-polyamine-morpholine-modified QDs can act as potential fluorescent probes for cells.
Figure 4 Confocal images of HeLa cells treated with CdSe/ZnS@L-Cys-MPPDA for 6 hrs at 37°C with different concentrations.
Figure 5 Confocal images of HeLa cells treated with CdSe/ZnS@L-Cys-MPPDA (200 μg/mL) at 37°C in the medium at different time.
To confirm the cell selectivity of the QDs in vitro, HT-29, HepG2, SMMC-7721 and HeLa cells were incubated with CdSe/ZnS@L-Cys-MPPDA QDs. After incubation for 6 hrs with QDs, the cells were washed. And the images of cells were collected under CLSM. As shown in Figure 6, the fluorescence intensity of CdSe/ZnS@L-Cys-MPPDA QDs in SMMC-7, HepG2, and HT-29 cells was weak and little to no fluorescence was observed. However, the fluorescence intensity of CdSe/ZnS@L-Cys-MPPDA QDs in HeLa cells was strong. These results provide strong evidence to suggest CdSe/ZnS@L-Cys-MPPDA QDs have strong HeLa cells targeting ability.
Figure 6 Confocal images of different cells treated with CdSe/ZnS@L-Cys-MPPDA (200 μg/mL) for 6 hrs at 37°C.
In addition, labeling of subcellular compartments by QDs was of particular importance. To further study targeting and localization of modified QDs in cells, we stained HeLa cells with the lysosome green fluorescent probe LysoTracker Green DND-26, and observed distribution of QDs in HeLa cells using laser confocal microscopy. As can be seen from Figure 7, the fluorescence of CdSe/ZnS@L-Cys-MPPDA QDs demonstrated complete co-localization with lysosomes in HeLa cells. Evaluation of the staining patterns and co-localization demonstrated that CdSe/ZnS@L-Cys-MPPDA QDs remained intact following uptake and had a perinuclear distribution; therefore, these results suggest that QDs are predominantly confined within lysosomes. This evidence indicates that nearly all cysteine-polyamine-morpholine-modified QDs were transported inside lysosomes without release to the cytoplasm or nucleus. Lysosome targeting of modified QDs may be attributed to the morpholine group of ligand cysteine-polyamine-morpholine.
Figure 7 The CdSe/ZnS@L-Cys-MPPDA QDs display co-localization with lysosomes in HeLa cells.
In conclusion, a new class of fluorescence probes, L-cysteine-polyamine-morpholine-modified QDs was synthesized in this work. These modified QDs had good water solubility and dispersed evenly. And the modified QDs had lower cytotoxicity to cells in vitro when compared to unmodified QDs. In addition, modified QDs had strong fluorescence intensity in HeLa cells and effectively targeted lysosome of HeLa cells. Therefore, modified QDs can efficiently enter cells and could be used as lysosome-targetable fluorescent probes.
Scheme 1 Schematic illustration of the formation of the L-Cys-MPA.
Scheme 2 Schematic illustration of the formation of the L-Cys-MPPDA and L-Cys-MBBDA.
Scheme 3 Schematic illustration of the formation of the L-Cys-AMPDA.
This work was supported by National Natural Science Foundation of China (21501044), Program for Innovative Research Talents from the University of Henan Province (18HASTIT049), Foundation of Science and Technology Department of Henan Province (182102410075), First-class Discipline Cultivation Project of Henan University-innovation Team Cultivation (2018YLTD10), Major Cultivation Project of First-class Discipline of Henan University (2019YLZDJL09), and Special Professor Project of Henan University.
All authors contributed to data analysis, drafting or revising the article, gave final approval of the version to be published, and agree to be accountable for all aspects of the work.
The authors report no conflicts of interest in this work.
1. Pidluzhna А, Ivaniuk K, Stakhira P, et al. Multi-channel electroluminescence of CdTe/CdS core-shell quantum dots implemented into a QLED device. Dyes Pigm. 2019;162:647–653. doi:10.1016/j.dyepig.2018.10.074
2. McAdams SG, Lewis DJ, McNaughter PD, et al. High magnetic relaxivity in a fluorescent CdSe/CdS/ZnS quantum dot functionalized with MRI contrast molecules. Chem Commun. (Camb). 2017;53(76):10500–10503. doi:10.1039/C7CC05537D
3. Zhao M-X, Zeng E-Z, Zhu B-J. The biological applications of inorganic nanoparticle drug carriers. ChemNanoMat. 2015;1:82–91. doi:10.1002/cnma.201500036
4. Yang HY, Fu Y, Jang MS, et al. CdSe@ZnS/ZnS quantum dots loaded in polymeric micelles as a pH-triggerable targeting fluorescence imaging probe for detecting cerebral ischemic area. Colloids Surf B Biointerfaces. 2017;155:497–506. doi:10.1016/j.colsurfb.2017.04.054
5. Li Q, Peng H, Wang J, Wang Y, Guo F. Coexpression of CdSe and CdSe/CdS quantum dots in live cells using molecular hyperspectral imaging technology. J Biomed Opt. 2015;20(11):110504. doi:10.1117/1.JBO.20.11.110504
6. Oliveira E, Santos HM, Jorge S, et al. Sustainable synthesis of luminescent CdTe quantum dots coated with modified silica mesoporous nanoparticles: towards new protein scavengers and smart drug delivery carrier. Dyes Pigm. 2019;161:360–369. doi:10.1016/j.talanta.2018.02.063
7. Tan L, Ge J, Jiao M, Jie G, Niu S. Amplified electrochemiluminescence detection of DNA based on novel quantum dots signal probe by multiple cycling amplification strategy. Talanta. 2018;183:108–113. doi:10.1016/j.talanta.2018.02.063
8. Dong X, Ren J, Li T, Wang Y. Synthesis, characterization and application of red-emitting CuInS2/ZnS quantum dots for warm white light-emitting diodes. Dyes Pigm. 2019;165:273–278. doi:10.1016/j.dyepig.2019.02.035
9. Zhao M-X, Zhu B-J, Yao W-J, Chen D-F, Wang C. The delivery of doxorubicin of multifunctional β-cyclodextrin-modified CdSe/ZnS quantum dots for bioactivity and nano-probing. Chem Biol Drug Des. 2018;91:285–293. doi:10.1111/cbdd.13080
10. Kumari A, Sharma A, Malairaman U, Singh RR. Proficient surface modification of CdSe quantum dots for highly luminescent and biocompatible probes for bioimaging: a comparative experimental investigation. J Lumin. 2018;199:174–182. doi:10.1016/j.jlumin.2018.03.032
11. Bach LG, Nguyen TD, Thuong NT, Van HTT, Lim KT. Glutathione capped CdSe quantum dots: synthesis, characterization, morphology, and application as a sensor for toxic metal ions. J Nanosci Nanotechnol. 2019;19(2):1192–1195. doi:10.1166/jnn.2019.15924
12. Zhao M-X, Zhu B-J, Yao W-J, Chen D-F. Therapeutic effect of quantum dots for cancer treatment. RSC Adv. 2016;6:113791–113795. doi:10.1039/C6RA24063A
13. Swart I, Liljeroth P, Vanmaekelbergh D. Scanning probe microscopy and spectroscopy of colloidal semiconductor nanocrystals and assembled structures. Chem Rev. 2016;116(18):11181–11219. doi:10.1021/acs.chemrev.5b00678
14. Lim SJ, Ma L, Schleife A, Smith AM. Quantum dot surface engineering: toward inert fluorophores with compact size and bright, stable emission. Coord Chem Rev. 2016;320–321:216–237. doi:10.1016/j.ccr.2016.03.012
15. Shuang W, Wang XB, Wang G, et al. Facile and controlled synthesis of stable water-soluble cupric sulfide quantum dots for significantly inhibiting the proliferation of cancer cells. J Mater Chem B. 2015;3(27):5603–5607. doi:10.1039/C5TB00960J
16. Zhao M-X, Zeng E-Z. Application of functional quantum dot nanoparticles as fluorescence probes in cell labeling and tumor diagnostic imaging. Nanoscale Res Lett. 2015;10:171. doi:10.1186/s11671-015-0873-8
17. Wang C, Gao X, Su X. In vitro and in vivo imaging with quantum dots. Anal Bioanal Chem. 2010;397(4):1397–1415. doi:10.1007/s00216-010-3481-6
18. Bilan R, Nabiev I, Sukhanova A. Quantum dot-based nanotools for bioimaging, diagnostics, and drug delivery. Chembiochem. 2016;17(22):2103–2114. doi:10.1002/cbic.v17.22
19. Soenen SJ, Parak WJ, Rejman J, Manshian B. (Intra) cellular stability of inorganic nanoparticles: effects on cytotoxicity, particle functionality, and biomedical applications. Chem Rev. 2015;115(5):2109–2135. doi:10.1021/cr400714j
20. Han X, Lei J, Chen K, et al. Cytotoxicity of CdTe quantum dots with different surface coatings against yeast Saccharomyces cerevisiae. Ecotoxicol Environ Saf. 2019;174:467–474. doi:10.1016/j.ecoenv.2019.03.013
21. Zhao M-X, Zeng E-Z, Li Y, Wang C-J. A study on effects of naphthalimide derivative-capped quantum dots on the cellular internalization, proliferation, and apoptosis ability. J Mater Chem B. 2014;2:7351–7359. doi:10.1039/C4TB01048E
22. Liang X, Tang M. Research advances on cytotoxicity of cadmium-containing quantum dots. J Nanosci Nanotechnol. 2019;19:5375–5387. doi:10.1166/jnn.2019.16783
23. Mirnajafizadeh F, Ramsey D, McAlpine S, Wang F, Stride JA. Nanoparticles for bioapplications: study of the cytotoxicity of water dispersible CdSe(S) and CdSe(S)/ZnO quantum dots. Nanomaterials (Basel). 2019;9(3):E465. doi:10.3390/nano9030465
24. Yukawa H, Baba Y. In vivo fluorescence imaging and the diagnosis of stem cells using quantum dots for regenerative medicine. Anal Chem. 2017;89(5):2671–2681. doi:10.1021/acs.analchem.6b04763
25. Guo J-W, Wu Y-H, Wei P-L, Huang Y-J, Chen J-K. Immobilization of antibody conjugated ZnS quantum dots onto poly(2,6-dimethyl-1,4-phenylene oxide) nanofibers with poly (N-isopropylacrylamide) grafts as reversibly fluorescence immunoassay. Dyes Pigm. 2018;159:198–208. doi:10.1016/j.dyepig.2018.05.059
26. Taniguchi S, Sandiford L, Cooper M, et al. Hydrophobin-encapsulated quantum dots. ACS Appl Mater Interfaces. 2016;8(7):4887–4893. doi:10.1021/acsami.5b11354
27. Zhao M-X, Li Y, Zeng E-Z, Wang C. The application of CdSe quantum dots with multicolor emission as fluorescent probes for cell labeling. Chem Asian J. 2014;9:1349–1355. doi:10.1002/asia.201301692
28. Suzuki M, Udaka H, Fukuda T. Quantum dot-linked immunosorbent assay (QLISA) using orientation-directed antibodies. J Pharm Biomed Anal. 2017;143:110–115. doi:10.1016/j.jpba.2017.05.014
29. Liu H, Sun Y, Li Z, et al. Lysosome-targeted carbon dots for ratiometric imaging of formaldehyde in living cells. Nanoscale. 2019;11(17):8458–8463. doi:10.1039/C9NR01678C
30. Li Z, Wang Y, Wang J, Tang Z, Pounds JG, Lin Y. Rapid and sensitive detection of protein biomarker using a portable fluorescence biosensor based on quantum dots and a lateral flow test strip. Anal Chem. 2010;82(16):7008–7014. doi:10.1021/ac101405a
31. Ma Q, Wang C, Su X. Synthesis and application of quantum dot-tagged fluorescent microbeads. J Nanosci Nanotechnol. 2008;8(3):1138–1149. doi:10.1166/jnn.2008.308
32. Silva AC, Freschi AP, Rodrigues CM, et al. Biological analysis and imaging applications of CdSe/CdSxSe1-x/CdS core-shell magic-sized quantum dot. Nanomedicine. 2016;12(5):1421–1430. doi:10.1016/j.nano.2016.01.001
33. Zhao M-X, Zhu B-J. The research and applications of quantum dots as nano-carriers for targeted drug delivery and cancer therapy. Nanoscale Res Lett. 2016;11:207. doi:10.1186/s11671-016-1394-9
34. Shibu ES, Hamada M, Nakanishi S, Wakida S, Biju V. Photoluminescence of CdSe and CdSe/ZnS quantum dots: modifications for making the invisible visible at ensemble and single-molecule levels. Coord Chem Rev. 2014;263:2–12. doi:10.1016/j.ccr.2013.10.014
35. Wijaya H, Darwan D, Lim KRG, Wang T, Khoo KH, Tan ZK. Large-stokes-shifted infrared-emitting InAs-In(Zn) P-ZnSe-ZnS giant-shell quantum dots by one-pot continuous-injection synthesis. Chem Mater. 2019;31(6):2019–2026. doi:10.1021/acs.chemmater.8b05023
36. Higuchi CM, Wang W. Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J Cell Biochem. 1995;57(2):256–261. doi:10.1002/(ISSN)1097-4644
37. Bae DH, Lane DJR, Jansson PJ, Richardson DR. The old and new biochemistry of polyamines. Biochim Biophys Acta Gen Subj. 2018;1862(9):2053–2068. doi:10.1016/j.bbagen.2018.06.004
38. Weiger TM, Hermann A. Cell proliferation, potassium channels, polyamines and their interactions: a mini review. Amino Acids. 2014;46(3):681–688. doi:10.1007/s00726-013-1536-7
39. Janne J, Poso H, Raina A. Polyamines in rapid growth and cancer. Biochim Biophys Acta. 1978;473(3–4):241–293. doi:10.1016/0304-419x(78)90015-x
40. van Biljon R, Niemand J, van Wyk R, et al. Inducing controlled cell cycle arrest and re-entry during asexual proliferation of Plasmodium falciparum malaria parasites. Sci Rep. 2018;8(1):16581. doi:10.1038/s41598-018-34964-w
41. König SG, Krämer R. Polyamine-modified near-infrared cyanine dyes for targeting the nuclei and nucleoli of cells. Dyes Pigm. 2017;145:80–94. doi:10.1016/j.dyepig.2017.05.041
42. Frau M, Feo F, Pascale RM. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis. J Hepatol. 2013;59(4):830–841. doi:10.1016/j.jhep.2013.04.031
43. Zhang L, Lee HK, Pruess TH, White HS, Bulaj G. Synthesis and applications of polyamine amino acid residues: improving the bioactivity of an analgesic neuropeptide, neurotensin. J Med Chem. 2009;52(6):1514–1517. doi:10.1021/jm801481y
44. Bisceglia JA, Mollo MC, Gruber N, Orelli LR. Polyamines and related nitrogen compounds in the chemotherapy of neglected diseases caused by kinetoplastids. Curr Top Med Chem. 2018;18(5):321–368. doi:10.2174/1568026618666180427151338
45. Benincasa M, Francescon M, Fregonese M, et al. Helical peptide-polyamine and -polyether conjugates as synthetic ionophores. Bioorg Med Chem. 2015;23(23):7386–7393. doi:10.1016/j.bmc.2015.10.034
46. Huang Z, Gengenbach T, Tian J, Shen W, Garnier G. The role of polyaminoamide-epichlorohydrin (PAE) on antibody longevity in bioactive paper. Colloids Surf B Biointerfaces. 2017;158:197–202. doi:10.1016/j.colsurfb.2017.07.005
47. Yang S, Guo W, Sun X. Electrostatic association complex of a polymer capped CdTe(S) quantum dot and a small molecule dye as a robust ratiometric fluorescence probe of copper ions. Dyes Pigm. 2018;158:114–120. doi:10.1016/j.dyepig.2018.05.031
48. Han C, Li H. Chiral recognition of amino acids based on cyclodextrin-capped quantum dots. Small. 2008;4(9):1344–1350. doi:10.1002/smll.v4:9
49. Zhao M-X, Ji L-N, Mao Z-W. β-Cyclodextrin/glycyrrhizic acid functionalised quantum dots selectively enter hepatic cells and induce apoptosis. Chem Eur J. 2012;18:1650–1658. doi:10.1002/chem.v18.6
50. Cunha CRA, Oliveira ADPR, Firmino TVC, et al. Biomedical applications of glyconanoparticles based on quantum dots. Biochim Biophys Acta Gen Subj. 2018;1862(3):427–439. doi:10.1016/j.bbagen.2017.11.010
51. Wang Y, Tang M. Dysfunction of various organelles provokes multiple cell death after quantum dot exposure. Int J Nanomedicine. 2018;13:2729–2742. doi:10.2147/IJN
52. Delehanty JB, Blanco-canosa JB, Bradburne CE, et al. Site-specific cellular delivery of quantum dots with chemoselectively-assembled modular peptides. Chem Commun. (Camb). 2013;49(72):7878–7880. doi:10.1039/c3cc42781a
53. Zayed DG, AbdElhamid AS, Freag MS, Elzoghby AO. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging. Nanomedicine (Lond). 2019;14(3):225–228. doi:10.2217/nnm-2018-0414
54. Hosseini M, Ganjali MR, Vaezi Z, et al. Selective recognition histidine and tryptophan by enhanced chemiluminescence ZnSe quantum dots. Sensor Actuat B-Chem. 2015;210:349–354. doi:10.1016/j.snb.2015.01.002
55. Xing R, Chen XD, Zhou YF, et al. Targeting and retention enhancement of quantum dots decorated with amino acids in an invertebrate model organism. Sci Rep. 2016;6:19802. doi:10.1038/srep19802
56. Raju BR, Garcia AMF, Costa ALS, Coutinho PJG, Gonçalves MST. Synthesis of new benzo[a]phenoxazinium probes possessing carboxylic ester, hydroxyl and amino functional groups: photophysical studies in dry ethanol and conjugation with CdTe quantum dots. Dyes Pigm. 2014;110:203–213. doi:10.1016/j.dyepig.2014.04.006
57. Feng W, Feng G. A lysosome-targetable fluorescent probe for imaging ONOO− in living cells and animals. Dyes Pigm. 2019;164:174–181. doi:10.1016/j.dyepig.2019.01.028
58. Guo W, Li JJ, Wang YA, Peng X. Luminescent CdSe/CdS core/shell nanocrystals in dendron boxes: superior chemical, photochemical and thermal stability. J Am Chem Soc. 2003;125(13):3901–3909. doi:10.1021/ja028469c
59. Xu H, Li D, Zhao Y, Wang X, Li D, Wang Y. Sodium 4-mercaptophenolate capped CdSe/ZnS quantum dots as a fluorescent probe for pH detection in acidic aqueous media. Luminescence. 2018;33(2):410–416. doi:10.1002/bio.3428
60. Wichner SM, Mann VR, Powers AS, et al. Covalent protein labeling and improved single-molecule optical properties of aqueous CdSe/CdS quantum dots. ACS Nano. 2017;11(7):6773–6781. doi:10.1021/acsnano.7b01470
© 2020 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.